Rodman & Renshaw Acts as Exclusive Placement Agent to BioSante Pharmaceuticals,on $18.0 Million RDO

Rodman & Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc. RODM, announced that it acted as the exclusive placement agent to BioSante Pharmaceuticals Inc. BPAX on the Company's $18.0 million registered direct offering.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsOfferingsBiotechnologyFinancialsHealth CareInvestment Banking & Brokerage
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!